Abstract. Previous studies have demonstrated that asiatic acid (AA), the major component of Centella asiatica, is able to meditate cytotoxic and anticancer effects on various types of carcinoma cells. In order to investigate the molecular mechanism that underlies the antitumor effect of AA, the present study investigated the effects of AA on proliferation, migration and apoptosis of SW480 and HCT116 colon cancer cells. Viability and changes in cell morphology in the cells were assessed by MTT assay and transmission electron microscopy, respectively. Colony formation analysis was used to observe proliferation of the single cell, and migratory ability of the cells was assessed by performing Transwell migration assay. Hoechst 33342 nuclear staining and flow cytometry were used to assess apoptosis in colon carcinoma cells. The expression of proteins associated with the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR)/p70S6K signaling pathway and epithelial-mesenchymal transition (EMT) marker were analyzed by western blotting. The present study revealed that proliferation and migration of colon carcinoma cells were inhibited by AA in a dose-dependent and time-dependent manner. Numerous apoptotic bodies were observed, and G 2 /M and S phase progression were delayed in colon cancer cells treated with AA, but not in the control group. A number of phosphorylated proteins, including PI3K, Akt (Ser 473 ), mTOR, ribosomal protein S6 kinase (p70S6K) downregulated, while the expression of Pdcd4 was upregulated following treatment with AA. Additionally, AA affects expression of EMT markers in a dose-dependent manner. On the basis of these results, it was concluded that AA inhibited proliferation, migration and induced apoptosis of colon cancer cells by regulating Pdcd4 via the PI3K/Akt/mTOR/p70S6K signaling pathway. These observations suggest that AA may be a potential therapeutic agent for the treatment of colon carcinoma.
Introduction
Colorectal cancer (CRC) is one of the most common types of cancer worldwide (1) . The changes in the Chinese diet and lifestyle have contributed to CRC in becoming the third leading cause of cancer mortality in China (2) . Despite recent advances in the surgical treatment, chemoprevention has emerged as an indispensable option for the treatment of CRC (3) . The poor prognosis of patients with CRC is primarily due to primary tumor spread and metastasis (4) . Therefore, cancer metastasis is one of the important causes of mortality in patients with CRC (5) .
Plant-derived compounds are a major source for cancer therapy. Triterpenoids have attracted much attention for their effective antitumor activities. Asiatic acid (AA; 2α, 3β, 23-trihydroxy-12-ursen-28-oic acid, C 30 H 48 O 5 ) (4,6,7), a naturally occurring pentacyclic triterpenoid, is present in a variety of plants, including Centella asiatica, Purnella vulgaris, Nepeta hindostana, Eucalyptus perriniana and Psidium guajava. AA was primarily used as a dermatological topical agent to prevent ultraviolet A-mediated photo-aging and wounding healing (8) . Previous studies suggested that AA possessed a wide range of pharmacological properties, including antihepatofibric, neuroprotective, anti-inflammatory, anti-diabetic and antitumor activities (9) . As for antitumor effect, AA was reported to induce apoptosis in hepatic and breast cancer cell lines and other tumor cells (10, 11) . The efficacy of AA was possibly attributed to the inhibition of nuclear factor-κB, p38 mitogen-activated protein kinase and extracellular signal-regulated kinase, as well as the change of Bcl-2 and caspase family proteins. Despite the aforementioned widely described antitumor properties, further studies are required to investigate the anti-metastatic potential of AA and to investigate the molecular mechanisms of apoptosis induction and metastasis inhibition.
In the present study, apoptosis and antitumor effects of AA on human colon cancer cells (SW480 and HCT116), was evaluated, and this revealed the role of phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway in the underlying molecular mechanism.
Materials and methods
Materials. RPMI-1640 with 10% heat-inactivated fetal bovine serum (FBS) were purchased from Biological Industries (Kibbutz Beit-Haemek, Israel). Rapamycin was purchased from Selleck Chemicals (Houston, TX, USA). Antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). Hoechst 33342 dye was purchased from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). Fluorescein isothiocyanate (FITC)-labeled Annexin V and propidium iodide (PI) were purchased from Nanjing KeyGen Biotech. Co., Ltd. (Nanjing, China).
AA samples. AA previously isolated from the urban of Centella asiatica (Umbelliferae) was used (12) . These compounds used for the present study were analyzed by high-performance liquid chromatography and were >97% pure. AA was dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich; Merck KGaA) to make a stock solution at a concentration of 1 mg/ml, which was further diluted to the appropriate concentration with culture medium prior to each experiment.
Cell line and cell culture. The human colon cancer cells (SW480 and HCT116) were obtained from the Cancer Research Institute, Southern Medical University (Guangzhou, China). The cells were incubated in RPMI-1640 added with either 10% heat-inactivated FBS (both from Biological Industries), at 37˚C in a humidified atmosphere containing 5% CO 2 .
Cell viability assay. Cell viability was measured by MTT assay; cells without AA treatment were used as the control group. (Sigma-Aldrich; Merck KGaA). Subsequently, the cells (3x10 3 ) were seeded into 96-well plates (Nest Biotechnology Co., Ltd., Wuxi, China) and allowed to adhere following culture. After the cells were treated with 0, 10, 20, 30, 40 and 50 µg/ml of AA for various time-points from 24 to 72 h. A total of 15 µl MTT solution was added to each well for an additional 4 h at 37˚C, and 150 µl DMSO was also added into each well, followed by incubation at 37˚C for 10 min with gentle shaking. The absorbance value of each well was measured at 490 nm using a spectrophotometer (ELx800; BioTek Instruments, Inc., Winooski, VT, USA). The experiments were performed in triplicate.
Assessment of cell morphology. Abnormalities in cell morphology were observed using an optical microscope. Briefly, 5x10 5 cells were seeded into each well of 6-well plates (Nest Biotechnology Co., Ltd.) and allowed to adhere following culture. Subsequently, the cells were treated with 0, 15 and 25 µg/ml of AA for 24 h at 37˚C, and observed under an optical microscope (magnification, x100; Nikon TE2000; Nikon Corporation, Tokyo, Japan).
Colony formation assay. Cell proliferation was detected by colony formation assay. The cells were seeded into 6-well plates (Nest Biotechnology Co., Ltd.) at 2x10 2 cells/well. Following incubation for 24 h at 37˚C, the medium was replaced by fresh medium with 0, 15 and 20 µg/ml AA respectively. When there were visible colonies, incubation was stopped and the cells were stained. The number of colonies was under an optical microscope.
Migration assay. For migration assay, 1x10 2 cells in 200 µl RPMI-1640 were seeded into upper Transwell chamber with a 8.0-µm pore polycarbonate membrane insert (Nest Biotechnology Co., Ltd.). RPMI-1640 (600 µl) with 10% FBS was added into the lower chamber as a chemoattractant. After the cells were incubated for 8 h at 37˚C, the insert was washed with PBS, and the cells on the upper surface of the insert were gently removed by a cotton swab. The cells adhered to the lower surface were fixed by methanol, stained using 0.1% crystal violet at room temperature for 20 min and counted under an optical microscope in 6-8 predetermined fields. For each experiment, three independent filters were analyzed.
Analysis of apoptosis.
The cells were distributed into control and treatment groups with AA at 0, 15 and 20 µg/ml for 24 h. Following washing with PBS for 1-2 times, 5 µg/ml Hoechst 33342 dye was added to the cells. The cells were subsequently incubated in the dark for 5 min at room temperature. Then, the cells were observed with a fluorescence microscope (Nikon TE2000; Nikon Corporation) and were captured at 350 nm (excitation) and 460 nm (emission).
For analysis of apoptotic rate, flow cytometry (BD Biosciences, Franklin Lakes, NJ, USA) was used. Each cell line was maintained at a density of 2x10 5 cells in 6-well plates. Following treatment with AA, the cells were harvested, rinsed with ice-cold PBS, and were treated for 30 min with FITC-labeled Annexin V and PI (Nanjing KeyGen Biotech. Co. Ltd.) for 10 min at room temperature in the dark. Binding buffer (400 µl) was added to each tube according to the supplier's protocols, and the cells were analyzed with a flow cytometer within 1 h.
The cells were distributed into 6-well plates, and each cell group had three wells. Following incubation for 12 h at 37˚C, the cells were treated with AA from 0 to 25 µg/ml, respectively. To evaluate the DNA content, the nuclei were fixed in methanol, stained with 15 µg/ml of 4, 60-diamidino-2-phenylindole and 100 µg/ml DNase free RNase A for 30 min at 37˚C, rinsed twice with PBS. The DNA content of labeled cells was analyzed using fluorescence-activated cell sorting cytometry assay (BD Biosciences). All experiments were performed in triplicate.
Western blotting. The cells were harvested and lysed. 20 µg of protein/lane was separated by 10% SDS PAGE and transferred to polyvinylidene fluoride (PVDF) membranes. The membranes were incubated with the primary antibodies (all rabbit polyclonal antibodies were used at dilution, 1:1,000) including anti-epithelial (E-) cadherin (catalog no. 2500), anti-neural (N-) cadherin (catalog no. 13116), anti-vimentin (catalog no. 12020), anti-phosphorylated (-p) PI3K (catalog no. 3811), anti-PI3K (catalog no. 3821), anti-p Akt (Ser 473 ; catalog no. 5012), anti-Akt (catalog no. 4059), anti-p-mammalian target of rapamycin (mTOR; catalog no. 2974), anti-mTOR (catalog no. 2972), anti-p-p70S6K (catalog no. 9205), anti-p70S6K (catalog no. 9202), anti-programmed cell death 4 (Pdcd4; catalog no. 9535S), anti-β-actin (catalog no. 12620S) and anti-GAPDH (catalog no. 2118S) (all purchased from Cell Signaling Technology, Inc.) overnight at 4˚C, until they were blocked with 5% non-fat dried milk for 1 h at room temperature. Then, the immunoreactive bands were visualized by enhanced chemiluminescence using horseradish peroxidase-conjugated immunoglobulin G secondary antibodies (anti-rabbit; catalog no. 7074P2; dilution, 1:10,000; Cell Signaling Technology, Inc.). The bands were visualized by using an ECL western blot kit (Kangwei Biotech Co., Ltd., Beijing, China). The images were captured with ChemiDoc™ CRS and Molecular Imager (Bio-Rad Laboratories, Inc., Hercules, CA, USA).
Statistical analysis. All data are expressed as the mean value ± standard error from at least three independent experiments. The comparisons of different groups were performed using Student's t-test and one-way of variance (ANOVA). Statistical analyses were performed with the SPSS 13.0 statistical software package (SPSS Inc., Chicago, IL, USA). All statistical tests were two-sided, and P<0.05 was considered to be statistically significant.
Results

Inhibition of viability of colon carcinoma cells by AA.
MTT assay was used to determine the effects of AA on the viability of SW480 and HCT116 cells. The cells were treated with various concentrations of AA (0-50 µg/ml) for 24, 48, and 72 h. AA significantly inhibited the growth of SW480 and HCT116 cells in a dose-and time-dependent manner ( Fig. 1A and B ; P<0.05, P<0.01, P<0.001). Therefore, various concentrations (15, 20, and 25 µg/ml) of AA were selected for subsequent studies.
AA alters the morphology of colon carcinoma cells. The cells were treated with AA at 15 and 25 µg/ml for 24 h. The cells in the control groups grew markedly, while the cells in the drug-treated groups became small and pyknotic, and the cytoplasm was condensed. The cell organelles in the AA-treated groups were swollen, which confirmed that AA had cytotoxic effects on human colon carcinoma cells (Fig. 1C) .
AA inhibits proliferation and colony formation of colon carcinoma cells. Colony formation of SW480 and HCT116 cells was inhibited by AA treatment (Fig. 2A) . As expected, these cell lines treated with AA presented markedly reduced cell growth and colony formation compared with the control cell lines. The number of colonies treated with AA in groups significantly was reduced, which indicated that proliferation of single cells was also decreased.
AA reduces migration of colon carcinoma cells.
To gain an insight into the role of AA in migration and tumorigenesis of SW480 and HCT116 cells, the Transwell migration assay was performed (Fig. 2B) . It was demonstrated that the number of cells migrated in AA-treated groups was significantly reduced compared with the control. Together, the findings suggest that AA may reduce the migration of SW480 and HCT116 cells. Additionally, the number of SW480 cells migrated in the control group was higher compared to the number in the HCT116 control group. This result indicated that the migratory abilities of SW480 and HCT116 cells were different.
AA induces apoptosis of colon carcinoma cells.
To elucidate the underlying mechanism of apoptosis in colorectal carcinoma cells, whether AA is able to induce apoptosis in colon carcinoma cells was investigated by nuclear staining with Hoechst 33342.
Cytoplasmic agglutination, which is a characteristic of active apoptosis, was observed in SW480 and HCT116 cells, which have been treated for 24 h with 15 and 25 µg/ml AA. Cytoplasmic agglutination was not observed in the control groups (Fig. 3A) . Rates of apoptosis and cell cycle distribution were determined by flow cytometry. Flow cytometric analysis indicated the number of apoptotic cells was markedly higher in the AA-treated groups compared with the control, and this increase was concentration-dependent (Fig. 3B) . Additionally, the rate of apoptosis of the AA-treated groups were significantly higher compared with the control. Notably, an increase in apoptosis was observed in the sub-G1 population of SW480 and HCT116 cells treated with AA. There were also marked changes in cell cycle distribution with a decreased percentage of cells in the G1 phase and an increased percentage of cells in the G2/M and S phases, compared with the control (Fig. 3C ) (P<0.05).
Effects of AA on epithelial-mesenchymal transition (EMT) marker protein expression in colon carcinoma cells.
The expression of EMT-interrelated factors, as initiators of the metastatic cascade in the tumor cells, including vimentin, N-cadherin and E-cadherin were evaluated in the present study (Fig. 4A) . Consistent with the findings of the Transwell migration assay, it was observed that the level of E-cadherin expression was increased, while the expression of vimentin and N-cadherin was reduced in the AA-treated groups. These results indicated that AA-induced inhibition on migration in colon carcinoma cells may be associated with EMT.
AA meditates anticancer effects by regulating Pdcd4
via the PI3K/Akt/mTOR/p70S6K signaling pathway. The PI3K/Akt/mTOR/p70S6K signaling pathway is one of the major pathways, which regulate proliferation, apoptosis and migration of cancer cells (13) . Therefore, whether AA affects this pathway in colon carcinoma cells was investigated. As shown in Fig. 4B , treatment with AA markedly decreased the level of p-PI3K, p-Akt (Ser473), p-mTOR and p-p70S6K in a concentration dependent manner.
Additionally, the expression of Pdcd4 protein, downstream factor of p70S6K, was increased following treatment with AA. The mTOR inhibitor rapamycin was subsequently used to investigate whether the PI3K/Akt/mTOR/p70S6K signaling pathway is involved in the proliferation, migration and apoptosis of colon cancer cells. It was observed that pre-treating cells with AA and rapamycin further decreased the expression of mTOR and p70S6K, and increased the expression of Pdcd4, compared with untreated cells (Fig. 4C) . This finding suggests that AA partially exerts anticancer effect by regulating Pdcd4 via the PI3K/Akt/mTOR/p70S6K signaling pathway in colon cancer cells.
Discussion
In the present study, a novel role for AA on antitumor activity of colon cancer cells was revealed. It was demonstrated that AA was able to induce apoptosis and cell cycle arrest of colon carcinoma cells. Additionally, AA was able to modulate the expression of EMT marker proteins colon carcinoma cells. The expression of PI3K, Akt, mTOR, p70S6K total protein and phosphorylated proteins in AA-treated colon carcinoma cells was significantly reduced compared with the control group. This is in contrast to the upregulation of Pdcd4 expression observed in the AA-treated cells compared to the control group. This suggests that AA induced apoptosis by partially regulating Pdcd4 through the PI3K/Akt/mTOR/p70S6K signaling pathway.
AA has been reported to have an essential role in apoptosis, survival and proliferation in various types of carcinoma, including human hepatoma, breast cancer, non-small cell lung cancer cells, prostate cancer, glioblastoma, human melanoma, multiple myeloma, B-cell lymphoma and neuroblastoma cells (14) (15) (16) (17) (18) . The mechanisms of apoptosis primarily involve two signaling pathways: The mitochondrial death pathway and the cell death receptor pathway. Tang et al (19) previously demonstrated that AA is able to induce inhibition of growth of colon cancer cells and apoptosis through the mitochondrial death cascade. In the present study, it was found that AA was able to induce colon cancer cell growth and apoptosis by regulating the inhibition of the PI3K/Akt/mTOR/p70S6K signaling pathway, therefore suggesting a new potential mechanism for the effect of AA on apoptosis of colon carcinoma cells. Furthermore, it was indicated that AA may inhibit proliferation and migration of colon cancer cells.
As a critical event in the development of carcinoma cells, EMT, is a process whereby epithelial cells first lose cell-cell adhesion and cell polarity, followed by an increase in migratory and invasive properties to become mesenchymal stem cells (20, 21) . E-cadherin, N-cadherin and vimentin are three important promoters, which mediate migration and invasion of cancer cells through a number of signaling pathways (22, 23) . Therefore, the present study investigated the expression of EMT-associated factors. As expected, AA markedly increased the level of E-cadherin and decreased the levels of N-cadherin and vimentin in SW480 and HCT116, indicating the involvement of EMT in AA-induced inhibition of colon carcinoma cell migration.
PI3K/Akt/mTOR/P70S6K is an important signaling pathway, which regulates progression in numerous tumors (24) . This pathway controls cell proliferation, growth, translation, migration and survival, and over-activation of the signaling pathway is associated with poor prognosis (24) . There are a number of anticancer drugs, which mediate anticancer activity via the PI3K/Akt/mTOR/p70S6K axis. For example, by targeting the insulin-like growth factor 1 receptor, growth and metastasis can be significantly inhibited through suppression of the PI3K/Akt/mTOR/p70S6K signaling pathway (25) .
In addition, bone morphogenetic protein 9 has been shown to inhibit the proliferation and migration of breast cancer cells, and it was demonstrated that the PI3K/Akt/mTOR/p70S6K signaling pathway was involved in this process (25) . Furthermore, activation of the PI3K/Akt/mTOR/p70S6K signaling pathway has been shown to be involved in S100A4-induced viability and migration in CRC cells (26) .
Pdcd4 is a novel tumor suppressor protein that inhibits protein synthesis by suppressing translation (27, 28) . The PI3K/Akt/mTOR signaling pathway constitutively represses Pdcd4 expression in acute myelocytic leukemia. All-trans retinoic acid induces Pdcd4 through inhibition of the PI3K/Akt/mTOR signaling pathway (29) . Pdcd4 has also been shown to inhibit invasion by activating activator protein-1 (30) . Pdcd4 and PI3K/Akt/mTOR/p70S6K constitute an important pathway, which modulates multiple biological processes in carcinoma cells (31) . A limited number of studies have focused on the association between the PI3K/Akt signaling pathway and cancer cells that exhibit increased expression of Pdc4, including colon carcinoma cells. Notably, the present study found that AA was able to inhibit the PI3K/Akt/mTOR signaling pathway, which leads to apoptosis, an increase in the level of Pdcd4 expression and inhibition of cell invasion.
Taken together, the findings suggest that AA modulates the PI3K/AKT/mTOR signaling pathway, which affects cell proliferation, growth, translation, migration and survival. To the best of our knowledge, the present study is the first to describe the induction of apoptosis by AA by regulating Pdcd4 through the inhibition of the PI3K/Akt/mTOR/p70S6K signaling pathway Although therapeutics for the treatment of colon carcinoma remains at infancy, the present study suggests that AA may be a novel drug.
